ArticleDrug design, development and therapy2016

TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53.

Yinxiang Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.